药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Mecasermin
Roflumilast
Roflumilast may increase the immunosuppressive activities of Brentuximab vedotin.
Mecasermin
Tetrandrine
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tetrandrine.
Mecasermin
Bleselumab
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Bleselumab.
Mecasermin
Rozanolixizumab
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Rozanolixizumab.
Mecasermin
Risankizumab
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Risankizumab.
Mecasermin
Monomethyl fumarate
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Monomethyl fumarate.
Mecasermin
Fluclorolone
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Fluclorolone.
Mecasermin
Fluperolone
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Fluperolone.
Mecasermin
Begelomab
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Begelomab.
Mecasermin
Fluocortin
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Fluocortin.
Mecasermin
9-(N-methyl-L-isoleucine)-cyclosporin A
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Mecasermin
Hypericin
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Hypericin.
Mecasermin
Acteoside
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Acteoside.
Mecasermin
Deoxyspergualin
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Deoxyspergualin.
Mecasermin
Doxifluridine
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Doxifluridine.
Mecasermin
Trofosfamide
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Trofosfamide.
Mecasermin
Cepeginterferon alfa-2B
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Cepeginterferon alfa-2B.
Mecasermin
Gusperimus
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Gusperimus.
Mecasermin
Mizoribine
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Mizoribine.
Mecasermin
Ozanimod
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ozanimod.